interferon Archives

Antiphospholipid Antibodies And COVID-19 Vaccines.

25 August 2021

Background. As early as October 2020 – over ten months ago – we explained why a vaccine was not needed and would not be effective. That’s a vaccine using its correct medical definition, i.e. a prophylactic treatment providing long-term or lifetime protection. All of the four main treatment candidates being injected – Vaxzevria; BNT126b2; mRNA-1273 […]

COVID-19: The Western Diet Disease.

14 July 2021

The Poorer The Country, The Lower The Mortality Rate. This is the first pandemic in history where ‘poorer’ countries fare better, usually far better, then ‘richer’ ones. The more developed the country; industrialised the economy; advanced the healthcare system; widespread the adoption of Western lifestyle & diet, the higher the total deaths and in most […]

SARS-COV-2’s Defences Against Detection.

18 May 2021

What Variants Want. Considerable coverage is being given to variant B1.617. This is the ‘Indian’ variant if you use the incorrect basis of giving single country, geographical names to variants that appear globally across multiple variants and are not new, having been in existence for months and in some cases, over a year. As part […]

Rhinoviruses Increase SARS-CoV-2 Immunity.

31 March 2021

Persistent Antigen Exposure. We first highlighted persistent antigen exposure back in November 2020, when our research showed that individuals who had not previously had SARS-CoV-2 possessed memory T cells that recognised it, with this recognition likely coming from previous exposure to other common cold-causing coronaviruses. Public Health England that commissioned the report stated (with our […]